What's new

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised

Mar 5, 2025 - 12:51
 0
Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised
Read More

Tags:

Previous Article

Cox Automotive and DHL to open UK EV battery repair centre

Next Article

Human medicines European public assessment report (EPAR): Awiqli, Insulin icodec...

Related Posts

Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 10, 2025  0

Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline

Guideline on quality, non-clinical and clinical require...

Feb 9, 2025  0

Minutes of the PRAC meeting 25-28 November 2024

Feb 10, 2025  0